Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Return on Sales: 2020-2023

Historic Return on Sales for ADC Therapeutics (ADCT) over the last 3 years, with Sep 2023 value amounting to -2.76%.

  • ADC Therapeutics' Return on Sales fell 139.00% to -2.76% in Q3 2023 from the same period last year, while for Sep 2023 it was -2.76%, marking a year-over-year decrease of 139.00%. This contributed to the annual value of -0.73% for FY2022, which is 732.00% up from last year.
  • Latest data reveals that ADC Therapeutics reported Return on Sales of -2.76% as of Q3 2023, which was down 11.20% from -2.48% recorded in Q2 2023.
  • In the past 5 years, ADC Therapeutics' Return on Sales registered a high of 0.01% during Q2 2020, and its lowest value of -12.82% during Q3 2021.
  • In the last 3 years, ADC Therapeutics' Return on Sales had a median value of -2.48% in 2023 and averaged -4.23%.
  • Per our database at Business Quant, ADC Therapeutics' Return on Sales tumbled by 1,282bps in 2021 and then spiked by 1,144bps in 2022.
  • Over the past 4 years, ADC Therapeutics' Return on Sales (Quarterly) stood at 0.00% in 2020, then crashed by 1,282bps to -11.38% in 2021, then spiked by 1,064bps to -0.73% in 2022, then plummeted by 139bps to -2.76% in 2023.
  • Its last three reported values are -2.76% in Q3 2023, -2.48% for Q2 2023, and -1.07% during Q1 2023.